Compare TOI & LRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TOI | LRE |
|---|---|---|
| Founded | 2007 | 2001 |
| Country | United States | Japan |
| Employees | 641 | N/A |
| Industry | Medical/Nursing Services | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 304.4M | 16.8M |
| IPO Year | N/A | 2022 |
| Metric | TOI | LRE |
|---|---|---|
| Price | $3.97 | $1.23 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $6.67 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 8.8K |
| Earning Date | 05-07-2026 | 07-30-2015 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $30.15 | N/A |
| Revenue Next Year | $25.77 | N/A |
| P/E Ratio | ★ N/A | $3.16 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.02 | $1.00 |
| 52 Week High | $4.88 | $2.86 |
| Indicator | TOI | LRE |
|---|---|---|
| Relative Strength Index (RSI) | 58.84 | 33.93 |
| Support Level | $3.35 | $1.00 |
| Resistance Level | $4.15 | $1.43 |
| Average True Range (ATR) | 0.25 | 0.05 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 66.16 | 4.55 |
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.
Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa Prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment units to individual customers in Japan and Dallas, Texas. Its revenue is predominantly generated from developing and selling single-family homes and condominiums, hotel operations, and residential leasing. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.